2024 - Pros and cons in general internal medicine and geriatrics

This is a preview and has not been published.

2024 - Pros and cons in general internal medicine and geriatrics

Authors

  • Domenico Cucinotta Master in Geriatric Medicine, Ferrara & San Marino Universities; Past Chairman Dept of Internal Medicine and Aging, University Hospital Bologna

Keywords:

pros, cons, General Internal Medicine, geriatrics

Abstract

.

References

Cucinotta D. Forever Young: mission impossible? Acta Biomed. 2024;95(6):e2024152. doi: 10.23750/abm.v95i6.16343.

Smith G. Diana. The New York Times. 2024 Dec 3.

Obsessed with the LifeSpan. Aging2.0. 2024 Dec 9. Available from: www.aging2.com.

Clocchiatti-Tuozzo S, Rivier CA, Renedo D, Huo S, Hawkes MA, de Havenon A, et al. Life's Essential 8 and Poor Brain Health Outcomes in Middle-Aged Adults. Neurology. 2024 Nov 26;103(10).

Glandorf L, Wittmann B, Droux J, et al. Bessel beam optical coherence microscopy enables multiscale assessment of cerebrovascular network morphology and function. Light Sci Appl. 2024;13:307. doi: 10.1038/s41377-024-01649-1.

Feron J, Segaert K, Rahman F, Fosstveit SH, Joyce KE, Gilani A, et al. Determinants of cerebral blood flow and arterial transit time in healthy older adults. Aging (Albany NY). 2024 Sep 18;16(18):12473-12497. doi: 10.18632/aging.206112.

Lin YC, Yan HT. Frailty phenotypes and their association with health consequences: a comparison of different measures. Aging Clin Exp Res. 2024;36:233. doi: 10.1007/s40520-024-02887-4.

Hioka A, Akazawa N, Okawa N, Nagahiro S. Influence of aging on extracellular water-to-total body water ratio in community-dwelling females. Clin Nutr ESPEN. 2024 Apr;60:73-78. doi: 10.1016/j.clnesp.2024.01.007.

Cleland JGF. Aspirin for Secondary Prevention of Atherosclerosis-Evidence or Dogma? JAMA Cardiol. 2024 Dec 4. doi: 10.1001/jamacardio.2024.4335.

Coyle M, Lynch A, Higgins M, , et al. Risk of Intracranial Hemorrhage Associated With Direct Oral Anticoagulation vs Antiplatelet Therapy: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2024 Dec 2;7(12):e2449017. doi: 10.1001/jamanetworkopen.2024.49017.

Bliddal H, Bays H, Czernichow S, et al. Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis. N Engl J Med. 2024 Oct 31;391(17):1573-1583. doi: 10.1056/NEJMoa2403664.

Deanfield J, Verma S, Scirica BM, et al. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial. Lancet. 2024 Aug 24;404(10454):773-786. doi: 10.1016/S0140-6736(24)01498-3.

Packer M, Zile MR, Kramer CM, et al. Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity. N Engl J Med. 2024 Nov 16. doi: 10.1056/NEJMoa2410027.

Lähteenvuo M, Tiihonen J, Solismaa A, Tanskanen A, Mittendorfer-Rutz E, Taipale H. Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder. JAMA Psychiatry. 2025 Jan 1;82(1):94-98. doi: 10.1001/jamapsychiatry.2024.3599.

Lenzer J, Brownlee S. Donanemab: Conflicts of interest found in FDA committee that approved new Alzheimer's drug. BMJ. 2024 Sep 25;386:q2010. doi: 10.1136/bmj.q2010.

Ekström M, Andersson A, Papadopoulos S, et al. Long-Term Oxygen Therapy for 24 or 15 Hours per Day in Severe Hypoxemia. N Engl J Med. 2024 Sep 19;391(11):977-988. doi: 10.1056/NEJMoa2402638.

Kunadian V, Mossop H, Shields C, et al. Invasive Treatment Strategy for Older Patients with Myocardial Infarction. N Engl J Med. 2024 Nov 7;391(18):1673-1684. doi: 10.1056/NEJMoa2407791.

Trolle Lagerros Y, Grotta A, Freyland S, Grannas D, Andersson DP. Risk of Death in Patients With Coronary Artery Disease Taking Nitrates and Phosphodiesterase-5 Inhibitors. J Am Coll Cardiol. 2024 Jan 23;83(3):417-426. doi: 10.1016/j.jacc.2023.10.041..

Levine GN. Erectile Dysfunction and Coronary Artery Disease: Unfortunate Bedfellows. J Am Coll Cardiol. 2024 Jan 23;83(3):427-429. doi: 10.1016/j.jacc.2023.10.042..

Hu JC, Assel M, Allaf ME, et al. Transperineal vs Transrectal Prostate Biopsy. The PREVENT Randomized Clinical Trial. JAMA Oncol. 2024;10(11):1590-1593. doi: 10.1001/jamaoncol.2024.4000.

Daskivich TJ, Luu M, Heard J, Thomas IC, Leppert JT. Overtreatment of Prostate Cancer Among Men With Limited Longevity in the Active Surveillance Era. JAMA Intern Med. 2025 Jan 1;185(1):28-36. doi: 10.1001/jamainternmed.2024.5994.

Xia X, Yang Z, Lu Q, et al. Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy. Mol Cancer. 2024;23:175. doi: 10.1186/s12943-024-02079-8.

Padilla-Lopategui S, Ligorio C, Bu W, et al. Biocooperative Regenerative Materials by Harnessing Blood-Clotting and Peptide Self-Assembly. Adv Mater. 2024 Dec;36(52):e2407156. doi: 10.1002/adma.202407156.

Downloads

How to Cite

1.
Cucinotta D. 2024 - Pros and cons in general internal medicine and geriatrics. Acta Biomed. 96(1):16806. doi:10.23750/abm.v96i1.16806

Issue

Section

PROS AND CONS IN GENERAL MEDICINE

How to Cite

1.
Cucinotta D. 2024 - Pros and cons in general internal medicine and geriatrics. Acta Biomed. 96(1):16806. doi:10.23750/abm.v96i1.16806